Advent leverages Europe's fragmented landscape of 44 nations, each with unique regulations and politics. This complexity creates inefficiencies and transformational deal opportunities, like corporate carve-outs, which are less common in the more uniform US market.

American investors often underestimate the need for a physical management presence in Italy. Successful integration requires local leaders who can liaise with suppliers, customers, and authorities. Attempting to manage an Italian acquisition remotely from the US or another European hub is a common point of failure.

After acquiring a European company, SPS Commerce found success by sending leaders from all departments (finance, sales, back-office) to visit in person. A single executive "fly-by" is insufficient; integrating the whole business builds trust and operational alignment.

In Italy, the role of deal sourcing for mid-market companies has shifted from investment banks to law firms. Entrepreneurs now approach law firms first to explore a sale. These firms then discreetly connect them with potential buyers and advisors, acting as a less expensive, conflict-free starting point.

Don't assume selling in Europe is the same as North America; it constitutes a new market entry. Companies often make a 'ton of assumptions' about marketing data, buying cycles, language, and regulations, underestimating the difficulty and risk of the move.

In Italy, acquiring a business's assets doesn't grant the buyer the right to terminate existing employees due to redundancy. Labor laws are extremely strict and pro-employee. Buyers must often negotiate with trade unions pre-deal and commit to retention periods, as preserving jobs is a key concern for Italian sellers.

Unlike US startups serving one large market, Legora's Swedish origins necessitated immediate expansion into different countries with unique languages and laws. This built a core competency in multi-market operations, making global expansion a natural next step.

Complement Therapeutics intentionally built a presence across the UK, Germany, and the US to optimize talent acquisition. This cross-geographical structure allows them to hire the best experts in a specialized field like gene therapy, irrespective of their location, without being constrained by a single talent pool or dealing with complex relocations.

To properly enter Europe, Ramp didn't just open an office. Their strategy involved acquiring Billhop for local licenses and relocating a long-tenured employee to lead the effort. This demonstrates a comprehensive approach beyond a superficial market presence.